BACKGROUND: Candidemia is among the leading causes of nosocomial bloodstream
infections and is associated with significant mortality. Several centers have published data …

Methodology for testing natural compounds for determination of antifungal activity had been
developed with adaptations. The most used are bioautography and agar diffusion with a …

Antifungal activity of natural products has been tested by adapting methods designed for
synthetic drugs. In this study, two methods for the determination of antifungal activity of …

Background Candidemia is the worldwide life-threaten disease, especially in cancer
patients. This study was aimed to identify and evaluate the risk factors of candidemia in …

Introduction: Bloodstream infections due to Candida species are becoming a major cause of
morbidity and mortality in hospitalized patients. The spectrum of candidemia has changed …

Objective: The coronavirus disease 2019 (COVID-19) pandemic has caused a global health
crisis and may have affected healthcare-associated infection (HAI) prevention strategies. We …

Objectives Candidaemia carries a mortality of up to 40% and may be related to increasing
complexity of medical care. Here, we determined risk factors for the development of …

Candida glabrata bloodstream infection (BSI) isolates from a particular geographic area
have been reported to comprise a relatively small number of the major sequence types (STs) …

Objectives Candida auris is an emerging multidrug-resistant fungus that has been
associated with nosocomial outbreaks with high rates of mortality and transmission. The aim …

Background Hospital acquired fungal infections are defined as “never events”—medical
errors that should never have happened. Systemic Candida albicans infections results in 30 …